Booting Earth Optimization System
Thank you for your patience. Your civilization is very important to us.
Narrowband UVB Phototherapy
Treatment for Vitiligo
Typical Dosage: 2-3 sessions per week, gradually increasing dose from 200-300 mJ/cm²
Effectiveness
70%
Safety Score
70%
Clinical Trials
12
Participants
20K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
70
DangerousModerateSafe
Treatment Details
Dosage Range
2-3 sessions per week, gradually increasing dose from 200-300 mJ/cm²
Time to Effect
2-3 months
Treatment Duration
6-24 months
Evidence Quality
HIGHNumber Needed to Treat (NNT)
5(Treat 5 patients to see 1 additional successful outcome)
Confidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$300
Side Effect Mgmt:$100
Total Annual:$8,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTICER
$40,000/QALY
QALYs Gained
0.2
Outcome-Based Costs
Cost per Responder
$13,333.33
Cost per Remission
$32,000
Narrowband UVB Phototherapy Outcomes
for Vitiligo
Efficacy Outcomes
Overall Effectiveness
+70%
Response Rate
+60%
Remission Rate
+25%
Common Side Effects
Erythema
+60%
Pruritus
+25%
Dryness
+20%
Increased skin cancer risk (long-term)
+1%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
4 active trials recruiting for Narrowband UVB Phototherapy in Vitiligo
Tyrosine Vs Tacrolimus With NB-UVB in Vitiligo
NCT07532330ACTIVE NOT RECRUITINGNA
67 participants
INTERVENTIONAL
Minya, Egypt
Started: Aug 1, 2025
Possible Augmentation Of NB-UVB Induced Pigmentation In NSV By Carboxy.
NCT07563049ACTIVE NOT RECRUITINGPHASE4
59 participants
INTERVENTIONAL
Cairo, Egypt
Started: Sep 15, 2024
Melanotan II (MT-II) as an Adjunct to NB-UVB Phototherapy for Repigmentation in Stable Nonsegmental Vitiligo
NCT07437560RECRUITINGPHASE2
60 participants
INTERVENTIONAL
Shenzhen, China
Started: Feb 2, 2026
Vitiligo, New Treatment and Serum s100B
NCT06768840RECRUITINGPHASE2, PHASE3
50 participants
INTERVENTIONAL
Qina, Egypt
Started: Oct 2, 2024
Completed Clinical Trials
7 completed trials for Narrowband UVB Phototherapy in Vitiligo
Narrowband UVB Treatment in Patients With Vitiligo
NCT00398723COMPLETEDNA
20 participants
INTERVENTIONAL
New York, United States
Started: Nov 1, 2006
NB-UVB and PUVA Vitiligo Study
NCT01732965COMPLETEDPHASE4
10 participants
INTERVENTIONAL
Detroit, United States
Started: Mar 1, 2013
Clinical Study to Investigate the Safety and Effectiveness of RECELL for Repigmentation of Stable Vitiligo Lesions
NCT04547998COMPLETEDNA
25 participants
INTERVENTIONAL
Irvine, United States +11 more
Started: Sep 10, 2020
HI-Light Pilot Trial for Vitiligo: Hand Held NB-UVB for Early or Focal Vitiligo at Home
NCT01478945COMPLETEDNA
29 participants
INTERVENTIONAL
Nottingham, United Kingdom +1 more
Started: Feb 1, 2012
Combined Therapy With Narrow-Band Ultraviolet B Phototherapy and Apremilast for the Treatment of Vitiligo
NCT03123016COMPLETEDPHASE2
23 participants
INTERVENTIONAL
New York, United States
Started: Apr 14, 2017
Early Molecular Changes in Vitiligo After Narrowband Ultraviolet Therapy
NCT03270241COMPLETEDNA
10 participants
INTERVENTIONAL
Baltimore, United States
Started: Oct 1, 2017
Synergistic Effect of Vitamin D Supplementation in Patients With Vitiligo and Vitamin D Deficiency
NCT05364567COMPLETEDNA
29 participants
INTERVENTIONAL
Seoul, South Korea
Started: May 1, 2018